Related Experiment Videos
Cell cycle deregulation and xeroderma pigmentosum group C cell transformation
Edouard I Azzam1, Hatsumi Nagasawa, Yongjia Yu
1Laboratory of Radiobiology, Department of Cancer Cell Biology, Harvard School of Public Health, Boston, MA 02115, USA.
The Journal of Investigative Dermatology
|December 18, 2002
Summary
Xeroderma pigmentosum group C cells acquired mutations in the P53 gene, leading to loss of p53 protein function and cellular transformation. This involved progressive abnormalities in cell cycle regulators.
Area of Science:
- Genetics
- Cell Biology
- Cancer Research
Background:
- A xeroderma pigmentosum group C fibroblast cell strain (GM2995) exhibits genetic instability and transformation in vitro.
- Understanding genetic alterations during transformation is crucial for cancer research.
Purpose of the Study:
- To investigate genetic changes, specifically cell cycle regulator expression/function, during the in vitro transformation of xeroderma pigmentosum group C cells.
Main Methods:
- Serial cultivation of GM2995 cells.
- Analysis of P53 gene mutation and p53 protein function.
- Assessment of cell cycle regulators including p21Waf1, HDM2, retinoblastoma protein, p34cdc2, p27Kip1, and von Hippel-Lindau protein.
Main Results:
- A P53 gene mutation in exon 8 correlated with p53 protein loss of function and cell transformation.
- Abnormal p53 function was evidenced by lack of upregulation of p53 and its effectors upon irradiation.
- Deregulation included persistent retinoblastoma protein hyper-phosphorylation, aberrant p27Kip1 expression, and altered von Hippel-Lindau protein patterns.
Conclusions:
- Cellular transformation in this xeroderma pigmentosum group C strain involves progressive mutations.
- Acquisition of abnormalities in multiple cell cycle regulators drives the transformation process.